Photoselective vaporization of the prostate. Review of cost implementation to BPH treatment

被引:5
作者
Alivizatos, G. [1 ]
Skolarikos, A. [1 ]
机构
[1] NAtl & Kapodistrian Univ Athens, Athens Med Sch, Dept Urol 2, Sismanoglio Hosp, Kolonaki, Greece
关键词
BPH; KTP laser prostatectomy; cost; PVP;
D O I
10.1038/sj.pcan.4500950
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Effective treatment of benign prostatic hyperplasia (BPH) involves not only a reduction of symptom scores and the prevention of serious complications, but also an improvement in overall patient's quality of life and cost effectiveness. There is a paucity of data regarding cost effectiveness when the pharmacologic, the minimally invasive and the surgical treatments of BPH are compared. The potassium-titanyl-phosphate laser prostatectomy seems to be a safe and effective treatment option both in the short and in the long-term run. Preliminary results indicate that photoselective vaporization of the prostate is also a cost-effective method when compared to different minimally invasive treatments and to the transurethral prostatectomy.
引用
收藏
页码:S15 / S20
页数:6
相关论文
共 57 条
[1]  
[Anonymous], AHCPR PUBLICATION
[2]   Photoselective vaporization of the prostate:: The Basel experience after 108 procedures [J].
Bachmann, A ;
Ruszat, R ;
Wyler, S ;
Reich, O ;
Seifert, HH ;
Müller, A ;
Sulser, T .
EUROPEAN UROLOGY, 2005, 47 (06) :798-804
[3]  
BAHMANN A, 2005, EUR UROL, V48, P965
[4]   An economic evaluation of finasteride for treatment of benign prostatic hyperplasia [J].
Baladi, JF ;
Menon, D ;
Otten, N .
PHARMACOECONOMICS, 1996, 9 (05) :443-454
[5]  
Black L, 2006, AM J MANAG CARE, V12, pS99
[6]   Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: Part II - Results [J].
Blute, M ;
Ackerman, SJ ;
Rein, AL ;
Beusterien, K ;
Sullivan, EM ;
Tanio, CP ;
Strauss, MJ ;
Manyak, MJ .
UROLOGY, 2000, 56 (06) :981-987
[7]   KTP laser versus transurethral resection: Early results of a randomized trial [J].
Bouchier-Hayes, David M. ;
Anderson, Paul ;
Van Appledorn, Scott ;
Bugeja, Pat ;
Costello, Anthony J. .
JOURNAL OF ENDOUROLOGY, 2006, 20 (08) :580-585
[8]   Cost consequences of surveillance, medical management or surgery for benign prostatic hyperplasia [J].
Chirikos, TN ;
Sanford, E .
JOURNAL OF UROLOGY, 1996, 155 (04) :1311-1316
[9]   A pharmacoeconomic analysis ol patients with symptoms of benign prostatic hyperplasia [J].
Cockrum, PC ;
Finder, SF ;
Ries, AJ ;
Potyk, RP .
PHARMACOECONOMICS, 1997, 11 (06) :550-565
[10]  
DENIS L, 1998, P 4 INT CONS BEN PRO